Marshall Wace, LLP Dr Reddys Laboratories LTD Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $13.5 Million - $15.9 Million	-218,765 Reduced 88.6%	28,147 $1.88 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $11.7 Million - $13.9 Million	219,762 Added 809.44%	246,912 $15.6 Million
Q1 2023 May 15, 2023	SELL	$51.63 - $56.93 $1.11 Million - $1.23 Million	-21,585 Reduced 44.29%	27,150 $1.55 Million
Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $2.49 Million - $2.8 Million	48,735 New	48,735 $2.52 Million
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $707,978 - $829,398	-14,268 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $688,716 - $930,987	14,268 New	14,268 $795,000
Q1 2020 May 15, 2020	SELL	$34.75 - $45.85 $4.97 Million - $6.55 Million	-142,954 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.66 - $41.78 $97,662 - $111,301	-2,664 Reduced 1.83%	142,954 $5.8 Million
Q3 2019 Nov 14, 2019	BUY	$34.82 - $39.26 $5.07 Million - $5.72 Million	145,618 New	145,618 $5.52 Million

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.61B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.